Articles On Monash IVF Group (ASX:MVF)

Given how many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you. Three top ASX shares that leading brokers have named as...

ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and...

Nov 17 (Reuters) - Monash IVF Group Ltd: * NOTES MEDIA SPECULATION THAT MONASH IVF MAY BE SUBJECT OF A POTENTIAL CONTROL TRANSACTION * HAS NOT BEEN APPROACHED BY ANY POTENTIAL BIDDER REGARDING ANY POTENTIAL CONTROL TRANSACTION Source text f...

With so many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you. Three top ASX shares leading brokers have named as buys t...

ASX health stocks extend weekly gains on Friday as markets rally on back of promising US inflation figures Wound care company Avita rises 24% and biotech Antisense is up 18% for past five days Fertility company Monash IVF provides solid H1...

With so many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you. Three top ASX shares leading brokers have named as buys t...

ShareCafeUS investors wait for Friday’s jobs report: Cannabis stocks the highlight                    US stocks fell Thursday, as traders weighed sharp swings in stocks and rates to start the month. Investors are anxiously awaiting th...

ShareCafeUS markets bounce back as Europe looks to ‘winter from hell’                    Stocks rose Wednesday — trying to shake off a three-week slide — as rates and oil prices eased, cooling investor concerns about continued high in...

In the wake of ASX reporting season, we’ve seen droves of companies in the S&P/ASX All Ordinaries Index (ASX: XAO) turn ex-dividend in recent weeks. When a company’s shares turn ex-dividend, they no longer trade with the recent div...

The ASX healthcare index has fallen this week as a strong reporting season comes to a close with outlook still positive for FY23 Clinuvel Pharmaceuticals (ASX:CUV) jumps up more than 14% this week on positive FY22 results including revenue...

We’re almost at the end of reporting season, so it’s time to think about which ASX shares might have the best prospects after the flurry of numbers. Morgans analyst Andrew Tang cast his eyes over the company results and has nominated six A...

Today, Monday the 29th of August, we are happy to buy Wesfarmers Limited (ASX:WES), Ramsay Health Care (ASX:RHC), Universal Store (ASX:UNI), Peter Warren (ASX:PWR), Jumbo Interactive (ASX:JIN) and Monash IVF Group (ASX:MVF).

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX Powerplays. ASX health sector modestly up...

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

The takeover action evident at the top end of town is trickling down to the small and mid cap sectors, as mainly foreign marauders avail of the undervalued morsels on offer. In theory, the end of cheap money should have crimped takeover act...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in ASX health stocks. ASX health stocks get much needed July rally aft...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

ShareCafeEvening Report: 1 July, 2022 by Lauren Evans   The Australian sharemarket faded into the close, weighed down by US equity futures in a risk-off afternoon. The greenback rose against the Australian dollar, which has fallen to its lo...

01 Jul 2022 - Monash IVF (ASX:MVF) is set to acquire ART Associates Queensland in Brisbane for initial cash consideration of $3.9 million.

Memphasys (MEM) has enrolled and treated the first couple under a clinical study trialling the safety and performance of its Felix device The study is being conducted with reproductive and fertility services company Monash IVF Group and w...

There are two main ways that the ASX share market can deliver returns for investors – capital growth and dividends. What if there are some ASX dividend shares that are expected to deliver dividends and potentially grow in value? Experts...

ASX healthcare index finishes another week in the red Enterprise imaging stocks tipped to be a first recovery The goliath battle for fertility company Virtus comes to an end Healthcare and life sciences expert Scott Power – a senior analy...

ASX Health stocks endure another topsy-turvy week ending in red Monash IVF makes two key purchases to expand its foothold in fertility sector Actinogen Medical to push ahead with trial into treatment of early Alzheimer’s disease. Healthca...

Highlights Acquisitions have proven to be a great way for business expansion AHX has implemented binding agreements to acquire the assets of Victorian Equine Group and Romsey Veterinary Surgery Ramsay recently completed 100% acquisiti...

Monash IVF Group (MVF) acquires PIVET Medical Centre, marking its foray into the Western Australian IVF services market Monash IVF will pay an initial upfront cash consideration of $9.4 million, with the potential for additional earn out p...

Reproductive care specialist Monash IVF Group (ASX: MVF) has entered into a binding sale agreement to acquire Perth-headquartered PIVET Medical Centre (PIVET) for an initial upfront cost of $9.4 million. Founded in 1981 by in vitro fertili...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a strong gain. At the time of writing, the benchmark index is up 0.9% to 7,178.4 points. Four ASX shares that are rising more than most today are listed below....

Highlights Monash has inked a binding sale agreement to acquire PIVET Medical Centre, a fertility services provider based in Perth PIVET’s IVF Program resulted in Australia’s first IVF baby being born in 1982 An attractive growth oppo...

Monash IVF Group has made its first foray into the WA market with the acquisition of respected fertility services provider Pivet Medical Centre. 

ShareCafeLunch Report: 18 May, 2022 by Melissa Darmawan   Materials lift ASX higher for 4th day Australian shares are on track to continue its winning streak for its fourth straight day after taking a strong lead from Wall St. The local ind...

Highlights: The benchmark ASX 200 index was up 0.44% at 7,143.80 points in the opening trades on Wednesday The Materials and Information Technology sectors led gains today Andrew Forrest is back at the helm of Fortescue Metals Group’s...

The S&P/ASX 200 Index (ASX: XJO) is having a reasonably positive start to the week. In afternoon trade, the benchmark index is up 0.35% to 7,100 points. Four ASX shares that have failed to follow the market higher today are listed belo...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week on a positive note. At the time of writing, the benchmark index is up a sizeable 1.8% to 7,063.9 points. Four ASX shares that have failed to follow the m...

The S&P/ASX 200 Index (ASX: XJO) is back heading south again on Thursday afternoon. At the time of writing, the benchmark index is down 1.5% to 6,961 points. Four ASX shares that are falling more than most are listed below. Here’s why...

Highlights The Australian share market opened in the green on Wednesday. Investors now have their eyes set on the US Federal Reserve’s potential rate hike decision. In such a scenario, investors are in search of stocks with...

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

The ASX healthcare sector rebounds on back of $20 billion Ramsay Healthcare takeover bid Volpara founder and CEO steps into new role as female CEO takes the reins Medlab Clinical shares soar after UK trade deal for probiotic for patients...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

S&P/ASX 200 healthcare index modestly up 0.16% for week Gut health company Microba falls on IPO Rhythm Biosciences bowel cancer blood screening test milestone Have a habit of forgetting where you put your keys or mobile phone? You ma...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in ASX health stocks. Good news for coffee lovers, particularly those w...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Through the destruction of war...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. First a note on things are are...

Highlights The ASX 200 surged 0.61% to 7,316.7 in the first 15 minutes of trade. Gold prices rose on Wednesday after NATO and the US stated that Russia was deploying more troops near Ukraine border. The IT space has tumbled 2.13% so f...

At the time of writing, the ASX 200 Health Index (XHJ) is up by another 3.3%, while the benchmark ASX 200 has risen by 0.5%. Cancer and fibrosis focused biotech Amplia Therapeutics (ASX:ATX) said its AMP945 drug improves effectiveness of cu...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

It’s an exciting day for owners of these ASX small-cap shares – they’re hitting their highest share price in years. Shares in both Monash IVF Group Ltd (ASX: MVF) and Maggie Beer Holdings Ltd (ASX: MBH) are revelling in reporting season. T...

We go over the key stocks we are looking out for in the Healthcare sector this February Reporting Season. Stocks include; ResMed Inc (ASX:RMD), Pro Medicus (ASX:PME), Healius (ASX:HLS), Virtus Health (ASX:VRT), Monash IVF (ASX:MVF), and CSL...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Here’s something for anyone who...